Found 23 matching trials
The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI PHASE4 This study is aiming to test the hypothesis that efficacy of rhTNK-tPA was ...
Show More Location
Guangzhou Recomgen Biotech Co., Ltd.
Learn More & Join Trial
Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST) PHASE3 This is a randomized, rt-PA controlled, open-label phase 3 clinical study t...
Show More Location
Beijing Luhe Hospital,Capital Medical University
Learn More & Join Trial
A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke. PHASE2 The primary purpose of this trial is to compare the efficacy of different d...
Show More Location
Beijing Tiantan Hospital, Capital Medical University
Learn More & Join Trial
Mechanical Opening Device Implantation Following Intravenous r-tPA for Recanalization in Acute Ischemic Stroke PHASE2 This study is to test a hypothesis that temporary implantation of JRecanTM ...
Show More Location
Multiple Locations
Learn More & Join Trial
Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden PHASE4 The goal of this clinical trial is to compare the efficacy and safety of in...
Show More Location
Fuwai Central China Cardiovascular Hospital
Learn More & Join Trial
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) PHASE2 This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinv...
Show More Location
Gulf Health Hospitals d/b/a Thomas Hospital
Learn More & Join Trial
A Study of r-PA Treating Patients With Acute Ischemic Stroke(RAISE) PHASE3 The purpose of this study is to assess the efficacy and safety of recombina...
Show More Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism PHASE2 This trial is being conducted to assess the efficacy and safety of recombin...
Show More Learn More & Join Trial
Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization PHASE4 The goal of this clinical trial is to evaluate whether intra-arterial (IA) ...
Show More Location
Beijing Tiantan Hospital, Capital Medical University
Learn More & Join Trial
Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window. PHASE3 This is a multicenter, randomized, double-blind, placebo-controlled Phase I...
Show More Location
Puyang Oilfield General Hospital
Learn More & Join Trial